Virogates As Stock Fundamentals
| VIRO Stock | 6.00 0.02 0.33% |
ViroGates AS fundamentals help investors to digest information that contributes to ViroGates' financial success or failures. It also enables traders to predict the movement of ViroGates Stock. The fundamental analysis module provides a way to measure ViroGates' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ViroGates stock.
ViroGates |
ViroGates AS Company Return On Equity Analysis
ViroGates' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current ViroGates Return On Equity | -0.62 |
Most of ViroGates' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ViroGates AS is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, ViroGates AS has a Return On Equity of -0.6204. This is 97.41% lower than that of the Healthcare sector and 92.89% lower than that of the Medical Devices industry. The return on equity for all Denmark stocks is 100.13% higher than that of the company.
ViroGates AS Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining ViroGates's current stock value. Our valuation model uses many indicators to compare ViroGates value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ViroGates competition to find correlations between indicators driving ViroGates's intrinsic value. More Info.ViroGates AS is rated first in return on equity category among related companies. It is rated first in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value ViroGates by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for ViroGates' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ViroGates' earnings, one of the primary drivers of an investment's value.ViroGates Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ViroGates' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ViroGates could also be used in its relative valuation, which is a method of valuing ViroGates by comparing valuation metrics of similar companies.ViroGates is currently under evaluation in return on equity category among related companies.
ViroGates Fundamentals
| Return On Equity | -0.62 | |||
| Return On Asset | -0.39 | |||
| Profit Margin | (1.13) % | |||
| Operating Margin | (1.27) % | |||
| Current Valuation | 122.74 M | |||
| Shares Outstanding | 3.35 M | |||
| Shares Owned By Insiders | 49.55 % | |||
| Price To Book | 7.49 X | |||
| Price To Sales | 16.38 X | |||
| Revenue | 7.66 M | |||
| Gross Profit | 5.79 M | |||
| EBITDA | (18.55 M) | |||
| Net Income | (17.66 M) | |||
| Book Value Per Share | 5.34 X | |||
| Cash Flow From Operations | (21.44 M) | |||
| Earnings Per Share | (5.16) X | |||
| Number Of Employees | 10 | |||
| Beta | 1.44 | |||
| Market Capitalization | 191.08 M | |||
| Total Asset | 20.23 M | |||
| Net Asset | 20.23 M |
About ViroGates Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ViroGates AS's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ViroGates using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ViroGates AS based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| LTC | Litecoin | |
| STETH | Staked Ether | |
| LINK | Chainlink |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in ViroGates AS. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Complementary Tools for ViroGates Stock analysis
When running ViroGates' price analysis, check to measure ViroGates' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ViroGates is operating at the current time. Most of ViroGates' value examination focuses on studying past and present price action to predict the probability of ViroGates' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ViroGates' price. Additionally, you may evaluate how the addition of ViroGates to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |